Showing 20 of 83 recruiting trials for “Glioblastoma”
A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RecruitingNCT07411690 ↗
Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors
👨⚕️ Michal Senger, M.D., Department of Neurosurgery, Medical University of Warsaw, Warsaw, Poland📍 1 site📅 Started Feb 2026View details ↗
Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
5G-PEARL: Paxalisib in Malignant Brain Tumours
👨⚕️ Juanita Lopez, MD, PhD, National Health Service, United Kingdom📍 1 site📅 Started Jan 2026View details ↗
OT SMILE: Occupational Therapy Group Intervention for Primary Brain Tumour Patients
Enrolling by InvitationNCT07417774 ↗
Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic
Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients
A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
👨⚕️ David Peereboom, MD, Case Comprehensive Cancer Center, Cleveland Clinic Taussig Cancer Institute📍 1 site📅 Started Aug 2025View details ↗
CUE-102 in Recurrent Glioblastoma
ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
👨⚕️ Phioanh Nghiemphu, MD, UCLA / Jonsson Comprehensive Cancer Center📍 1 site📅 Started Jul 2025View details ↗
Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy
The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma
G-CSF After Chemo-radiation in Patients With Glioblastoma
Allogeneic γδT Cells in Glioblastoma
Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread
🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Apr 2025View details ↗
A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
Page 1 of 5Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →